Forschungsinstitut für Molekulare Pathologie

imp.ac.at
+43179730

Forschungsinstitut für Molekulare Pathologie GmbH (IMP)

Dr. Bohr-Gasse 7
1030 Wien
Austria
+43179730
imp.ac.at
Profile News

About Forschungsinstitut für Molekulare Pathologie

The IMP is a basic biomedical research institute, largely sponsored by Boehringer Ingelheim and through research grants from various national and international funding agencies. Our scientists are passionately committed to scientific discovery, seeking to unlock some of life’s fundamental mysteries.

Read more about Forschungsinstitut für Molekulare Pathologie
Facts about Forschungsinstitut für Molekulare Pathologie
  • Industry : Biology

News about Forschungsinstitut für Molekulare Pathologie

Forschungsinstitut für Molekulare Pathologie

28-Oct-2024 | business & finance

QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery

QUANTRO Therapeutics (QUANTRO), a pioneer in the discovery of first-in-class transcription factor targeting cancer treatments, announced that the company ...

Read news
Forschungsinstitut für Molekulare Pathologie

03-Jul-2024 | people

Eppendorf Award for Young European Investigators 2024 goes to Clemens Plaschka, Austria

In addition to the winner of the Eppendorf Award 2024, two finalists were honored: Irma Querques and Phong Nguyen

Read news
Forschungsinstitut für Molekulare Pathologie

28-Jul-2021 | science

A giant, snake-like enzyme seals the fate of unwanted proteins

A new study by scientists at the Research Institute of Molecular Pathology and Boehringer Ingelheim reveals the structure of a massive, snake-like enzyme ...

Read news
Forschungsinstitut für Molekulare Pathologie

09-Oct-2019 | science

Striking a balance: a mechanism to control autoimmunity

B cells are white blood cells that generate antibodies against an almost unlimited number of pathogens, a capacity that is vital for any higher organism. ...

Read news
Forschungsinstitut für Molekulare Pathologie

07-Dec-2018 | science

Scientists discover “brain hot spot” for drugs against fear

Findings could lead to a new therapeutic approach

Read news
Forschungsinstitut für Molekulare Pathologie

01-Oct-2018 | science

Principles of limb regeneration in salamanders show link to mammals

Scientists have long argued over which cells enable salamanders to grow back lost limbs. By tracking lineages and characterising individual cells, ...

Read news
Forschungsinstitut für Molekulare Pathologie

02-Jul-2018 | science

"Happiness hormone" controls fear memories

Scientists find that associative learning of fear is mediated by a novel dopamine circuit

Read news
Forschungsinstitut für Molekulare Pathologie

26-Jan-2018 | science

The largest genome ever

Decoding the Axolotl

Read news
Show more news about Forschungsinstitut für Molekulare Pathologie

Here you will find Forschungsinstitut für Molekulare Pathologie GmbH (IMP)

Last viewed contents

Antibody discovered that blocks almost all known HIV variants in neutralization assays - The discovery potentially opens up new perspectives for the prevention and treatment of HIV infections

Antibody discovered that blocks almost all known HIV variants in neutralization assays - The discovery potentially opens up new perspectives for the prevention and treatment of HIV infections

Go to page
New method for measuring luminescence lifetime offers breakthrough in scientific imaging - Ac­cel­er­at­ing the pace of dis­cov­ery in sci­ence and in­dustry

New method for measuring luminescence lifetime offers breakthrough in scientific imaging - Ac­cel­er­at­ing the pace of dis­cov­ery in sci­ence and in­dustry

Go to page
Decreasing biodiversity may promote spread of viruses - New insight into the dynamics of infectious disease

Decreasing biodiversity may promote spread of viruses - New insight into the dynamics of infectious disease

Go to page
Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies - Seed Capital from Forty51 Ventures to Advance Pipeline of Pan-PIM Kinase Inhibitors

Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies - Seed Capital from Forty51 Ventures to Advance Pipeline of Pan-PIM Kinase Inhibitors

Go to page
3D-printed pills with desired drug release – a step upwards in medication - Funny looking pills are not a design gimmick, they can release medication in a desired time regime!

3D-printed pills with desired drug release – a step upwards in medication - Funny looking pills are not a design gimmick, they can release medication in a desired time regime!

Go to page
Coronavirus SARS-CoV-2 spreads more indoors at low humidity - Indian-German research team recommends at least 40 percent humidity in public buildings

Coronavirus SARS-CoV-2 spreads more indoors at low humidity - Indian-German research team recommends at least 40 percent humidity in public buildings

Go to page
Chemische Fabrik Dr. Weigert GmbH & Co. KG - Hamburg, Germany

Chemische Fabrik Dr. Weigert GmbH & Co. KG - Hamburg, Germany

Go to page
KNAUER now officially a place of the future

KNAUER now officially a place of the future

Go to page
Microscopy: Overcoming the traditional resolution limit for the fast co-tracking of molecules - Researchers have developed an innovative method to simultaneously track rapid dynamic processes of multiple molecules at the molecular scale

Microscopy: Overcoming the traditional resolution limit for the fast co-tracking of molecules - Researchers have developed an innovative method to simultaneously track rapid dynamic processes of multiple molecules at the molecular scale

Go to page

Molecular simulations confirm role of functional rotation in multidrug resistance

Go to page
Pallmann Maschinenfabrik GmbH & Co. KG - Zweibrücken, Germany

Pallmann Maschinenfabrik GmbH & Co. KG - Zweibrücken, Germany

Go to page